$21.41
0.0450.21%
Last update: Dec 15, 12:20 PM
Comments
Loading...
Latest Avadel Pharmaceuticals Stock News | NASDAQ:AVDL | Benzinga
Get the latest news on Avadel Pharmaceuticals stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on Avadel Pharmaceuticals performance
Categories: All
Friday, December 05, 2025
Thursday, November 20, 2025
Wednesday, November 19, 2025
Monday, November 17, 2025
Friday, November 14, 2025
- Lundbeck's Higher Buyout Proposal Challenges Alkermes' Pending $2 Billion Avadel Deal
- Legence, Cidara Therapeutics, Avadel Pharmaceuticals, Omeros And Other Big Stocks Moving Higher On Friday
- Alkermes Says It Is Considering Options After...
- 12 Health Care Stocks Moving In Friday's Pre-Market Session
- Avadel Board Says Lundbeck Proposal May Be A ...
- Avadel Receives Unsolicited Lundbeck Proposal...
Friday, November 07, 2025
Tuesday, November 04, 2025
Tuesday, October 28, 2025
Friday, October 24, 2025
Thursday, October 23, 2025
Wednesday, October 22, 2025
- Alkermes Strikes $2.1 Billion Avadel Deal, Gains Access To Narcolepsy Drug Lumryz
- Beyond The Numbers: 5 Analysts Discuss Avadel Pharmaceuticals Stock
- Jefferies Downgrades Avadel Pharmaceuticals t...
- Needham Downgrades Avadel Pharmaceuticals to ...
- Trading Halt: Halt status updated at 7:15:00 ...
- Alkermes To Acquire Avadel Pharmaceuticals Pl...
- Trading Halt: Halted at 6:55:00 a.m. ET - Tra...
- Avadel Pharma Announces Global Settlement Of ...
